Severe SARS-CoV-2 disease in the context of a NF-κB2 loss-of-function pathogenic variant
NF-κB2 기능 상실 병원성 변이체의 맥락에서 심각한 SARS-CoV-2 질병
Case Reports
Published on
Journal: The Journal of Allergy and Clinical Immunology [Category] MERS, SARS, 변종, 진단, 치료제,
Journal: The Journal of Allergy and Clinical Immunology [Category] MERS, SARS, 변종, 진단, 치료제,
[키워드] acute respiratory distress
acute respiratory distress syndrome
acute respiratory syndrome
acute respiratory syndrome coronavirus
Affect
affecting
among others
appear
B-cell
biologic
biologic therapies
cardiovascular system
Central nervous system
Clinical management
combined immunodeficiency
common variable immunodeficiency
Complication
coronavirus
coronavirus disease
Coronavirus disease 2019
COVID-19
disease
dysregulation
evaluated
functional
Gain
gain-of-function
gastrointestinal tract
global pandemic
heterozygous variant
heterozygous variants
Hospitalization
Host
Host immune response
hyperinflammatory responses
immune
immune dysfunction
immune dysregulation
immunodeficiency
Infection
intrinsic
kidney
loss of function
loss-of-function
Lungs
male
management
mechanical ventilation
memory B cells
NF-κB
NF-κB pathway
NF-κB2
NFKB2
Novel coronavirus
nuclear
organ systems
outcome
pathogenic variant
Patient
patients with SARS-CoV-2
phenotype
reported
required
respiratory
respiratory distress
Respiratory distress syndrome
risk factor
SARS-CoV-2
SARS-CoV-2 disease
SARS-COV-2 infection
severe acute respiratory syndrome Coronavirus
severe acute respiratory syndrome coronavirus 2
severity of COVID-19
skin
susceptible
Symptom
symptomatic SARS-CoV-2 infection
syndrome
therapy
treat
variant
virus
[DOI] 10.1016/j.jaci.2020.09.020 PMC 바로가기 [Article Type] Case Reports
[DOI] 10.1016/j.jaci.2020.09.020 PMC 바로가기 [Article Type] Case Reports